Drug intelligence / Profile preview

maltosyl-alpha (1,4)-d-gluconhydroximo-1,5-lactam

Development stage
Unknown
Modality
Small Molecules
01

Overview

Maltosyl-alpha (1,4)-D-Gluconhydroximo-1,5-Lactam is a synthetic small molecule belonging to the class of o-glycosyl compounds and glycoconjugates[1][2][4]. It is structurally characterized as a complex carbohydrate derivative with the molecular formula C18H32N2O15[2][6]. This compound has been studied primarily as an experimental inhibitor of pancreatic alpha-amylase—a key enzyme involved in starch digestion—by binding to its active site and blocking enzymatic activity[8][10]. Its mechanism of action involves competitive inhibition of alpha-amylase activity. The compound has not been approved for clinical use and remains experimental.

Other names
MALTOSYL-α (1,4)-(Z,3S,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-piperidin-2-one oximeα-D-glucopyranoside (2R,3R,4R,5S)-2,3,4,5-tetrahydro-4,5-dihydroxy-6-(hydroxyamino)-2-(hydroxymethyl)-3-pyridinyl 4-O-α-D-glucopyranosyl-
02

Targets

PA (Influenza polymerase acidic protein)

Beyond the preview

Go deeper on maltosyl-alpha (1,4)-d-gluconhydroximo-1,5-lactam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on maltosyl-alpha (1,4)-d-gluconhydroximo-1,5-lactam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call